Trial Profile
Predictors of Antidepressant Treatment Response: The Emory CIDAR
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms PReDICT
- 16 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Apr 2012 Planned end date changed from 1 Oct 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.